Côd QR

Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model

Background To limit the use of antimicrobials without disincentivising the development of novel antimicrobials, there is interest in establishing innovative models that fund antimicrobials based on an evaluation of their value as opposed to the volumes used. The aim of this project was to evaluate t...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Sue Harnan, Ben Kearns, Alison Scope, Laetitia Schmitt, Dina Jankovic, Jean Hamilton, Tushar Srivastava, Harry Hill, Chu Chang Ku, Shijie Ren, Claire Rothery, Laura Bojke, Mark Sculpher, Beth Woods
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: NIHR Journals Library 2024-10-01
Cyfres:Health Technology Assessment
Pynciau:
ceftazidime-avibactam
colistin
drug resistance
bacterial
anti-bacterial agents
cost-effectiveness analysis
quality-adjusted life-years
network meta-analysis
oxacillinase
expert testimony
microbial sensitivity tests
systematic review
gram-negative bacterial infections
Mynediad Ar-lein:https://doi.org/10.3310/YAPL9347
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg